NARA Discovery
Article Details
← Back to Search Results
Journal Article

Low levels of the key B cell activation marker, HLA-DR, in COVID-19 hospitalized cases are associated with disease severity, dexamethasone treatment, and circulating IL-6 levels

Anthony Dobi; Arthur Dubernet; Mahary Lalarizo Rakoto; Anne-Laure Sandenon Seteyen; Damien Vagner; Grégorie Lebeau; Loïc Raffray; Philippe Gasque
Immunologic Research · Vol. 70, Issue 5 · pp. 714-719 · 2022
View Full Text Download RIS Journal Homepage

Abstract

Abstract is unavailable.

Bibliographic Information

JournalImmunologic Research
PublisherSpringer
Publication Date2022-10-01
Publication Year2022
Volume70
Issue5
Pages714-719
Document TypeJournal Article
eISSN1559-0755
DOI10.1007/s12026-022-09269-w

Access Information

NARA Access Coverage1982-01-01~Current
Journal Homepagehttps://www.springer.com/journal/12026
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.